Top entities: Micropep Technologies, United States, European Union, Kevin Leiner, Georg Goeres.

What category does this event fall under?

Regulatory — classified as regulatory filing.

What is the sentiment of coverage?

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Jul 30, 2026. Coverage continues to evolve.

Regulatory regulatory filing

Micropep submits Promisin regulatory dossiers

Q: When did this event occur?

First reported Jul 28, 2026; last updated Jul 30, 2026.

Q: What is the market impact?

General. The regulatory submissions mark a key step toward commercialization in major agricultural markets, potentially enhancing Micropep's valuation and partnership opportunities.

Analysis based on 6 articles · First reported Jul 28, 2026 · Last updated Jul 30, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The regulatory submissions mark a key step toward commercialization in major agricultural markets, potentially enhancing Micropep's valuation and partnership opportunities. However, market impact is limited as the product is still under regulatory review and not yet generating revenue.

agriculture biotechnology

Event Summary

Micropep Technologies, a French-American agtech company, announced the submission of regulatory dossiers for its lead peptide-based biofungicide Promisin in the United States and the European Union. This follows earlier filings in Brazil and Paraguay. The submissions cover fungal diseases of grapevine and potato in the US and EU, while Latin American filings focused on soy diseases. Promisin is developed using Micropep's proprietary Krisalix platform and has undergone over 200 field trials across three continents. The company aims to bring a novel peptide-based mode of action to broad-acre and high-value crops, addressing disease resistance and sustainability needs.

Key Actions

70 Micropep Technologies submitted regulatory dossiers

Entities Involved

priv

Micropep Technologies

Micropep is the central company advancing Promisin; the filings represent a milestone in its global commercialization strategy, potentially increasing its attractiveness to investors and partners.

Importance 100.0 Sentiment 40.0

cnt

United States

The US is a key market where regulatory dossiers were submitted for Promisin, covering grapevine and potato fungal diseases.

Importance 40.0 Sentiment 0.0

alliance

European Union

The EU is a key market where regulatory dossiers were submitted for Promisin, covering grapevine and potato fungal diseases.

Importance 40.0 Sentiment 0.0

per

Kevin Leiner

Kevin Leiner, Chief Regulatory Officer, announced the submissions and will lead the regulatory review process.

Importance 20.0 Sentiment 0.0

per

Georg Goeres

Georg Goeres, CEO, highlighted the significance of peptide-based solutions for agricultural adoption.

Importance 20.0 Sentiment 0.0

cnt

Brazil

Brazil was an earlier regulatory filing target for Promisin, focused on soy diseases.

Importance 20.0 Sentiment 0.0

cnt

Paraguay

Paraguay was an earlier regulatory filing target for Promisin, focused on soy diseases.

Importance 10.0 Sentiment 0.0

Relationships

United States related ↔ European Union

United States related ↔ Brazil

United States related ↔ Paraguay

European Union related ↔ Brazil

European Union related ↔ Paraguay

Brazil related ↔ Paraguay

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard